Clinical Trial Update: Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating sustained-release guanfacine for language-based learning skills in attention-deficit/hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Guanfacine Extended Release (guanfacine)

Snippet

Sponsor: Neurology Group of Bergen County, P.A. | Conditions: Attention-deficit/Hyperactivity Disorder | Phase 4 | Status: COMPLETED